E. Mickiewicz
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 2
-
- Lung Cancer Treatments and Mutations 3
- Advanced Breast Cancer Therapies 2
- Co-authors
- Camilla Fowst (1 shared paper)Neil K. Aaronson (1 shared paper)Per Eystein Lønning (1 shared paper)Luigi Celio (1 shared paper)Peter D. Eisenberg (1 shared paper)Emilio Bajetta (1 shared paper)E. Di Salle (1 shared paper)Robin Murray (1 shared paper)
In The Last Decade
E. Mickiewicz
14 papers receiving 600 citations
Peers
Comparison fields: 5 of 70
- Otorhinolaryngology 98
- Oncology 372
- Cancer Research 197
- Genetics 213
- Obstetrics and Gynecology 48
Countries citing papers authored by E. Mickiewicz
This map shows the geographic impact of E. Mickiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Mickiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Mickiewicz more than expected).
Fields of papers citing papers by E. Mickiewicz
This network shows the impact of papers produced by E. Mickiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Mickiewicz. The network helps show where E. Mickiewicz may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Mickiewicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 242 | |
| 2 | 1976 | 114 | |
| 3 | 2009 | 102 | |
| 4 | 1995 | 72 | |
| 5 | 2000 | 41 | |
| 6 | 2004 | 28 | |
| 7 | 2001 | 9 | |
| 8 | 1993 | 9 | |
| 9 | Gemcitabine/paclitaxel as first-line treatment of advanced breast cancer. | 2003 | 8 |
| 10 | Uracil/tegafur plus oral calcium folinate in advanced breast cancer. | 1999 | 6 |
| 11 | 2007 | 3 | |
| 12 | 2005 | 2 | |
| 13 | 1972 | 2 | |
| 14 | 2005 | 1 | |
| 15 | [Cytogenetic studies in Klinefelter's syndrome]. | 1987 | 0 |
About E. Mickiewicz
E. Mickiewicz is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Molecular Biology, having authored 15 papers that have together received 639 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers), Lung Cancer Treatments and Mutations (3 papers), Endometrial and Cervical Cancer Treatments (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Advanced Breast Cancer Therapies (2 papers), BRCA gene mutations in cancer (2 papers) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Otorhinolaryngology (98 citations), Oncology (372 citations), Cancer Research (197 citations), Genetics (213 citations) and Obstetrics and Gynecology (48 citations). E. Mickiewicz has collaborated with scholars based in Argentina, France and Australia. Frequent co-authors include Camilla Fowst, Neil K. Aaronson, Per Eystein Lønning, Luigi Celio, Peter D. Eisenberg, Emilio Bajetta, E. Di Salle, Robin Murray, Giorgio Massimini and M. Tubiana-Hulin. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, American Journal of Obstetrics and Gynecology, The Lancet and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.